The study showed semaglutide users were about three times more likely to develop gastroparesis than people taking another weight-loss pill and about six times more likely than people who had weight-loss surgery
Starting at a lower dose (e.g., 2 mg instead of 4 mg) helps reduce gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation, which are more common with higher initial doses
Mycoplasma contamination was checked in all used cells
Future Directions: Precision Medicine Through Bioinformatics As orforglipron moves toward potential FDA approval (expected 2025-2026), bioinformatics will continue to shape its clinical implementation
The role of GLP-1 in the nervous system remains inconclusive, yet indicates its potential for alleviating neuroinflammation, safeguarding neurons and glial cells from oxidative damage, and optimizing neurotransmitter equilibrium [83]